Who is sponsoring NCT04658836?

NCT04658836 is sponsored by Medical University of Vienna.

What drugs are being tested in NCT04658836?

Interventions in NCT04658836: Triamcinolone Acetonide 40mg/mL.

What condition does NCT04658836 study?

NCT04658836 studies Vestibular Schwannoma.

Is NCT04658836 still recruiting?

NCT04658836 is currently completed. Last updated 24 August 2022.

Last reviewed 2022-08-24 · How we verify

NCT04658836

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Triamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF

Completed Phase 1 Last updated 24 August 2022

What this trial tests

Phase 1 trial testing Triamcinolone Acetonide 40mg/mL in Vestibular Schwannoma in 21 participants. Completed in 31 October 2021.

Timeline

1 February 2020

Primary endpoint
31 August 2021

31 October 2021

Quick facts

Lead sponsor	Medical University of Vienna
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	21
Start date	1 February 2020
Primary completion	31 August 2021
Estimated completion	31 October 2021
Sites	1 location across Austria

Drugs / interventions tested

Triamcinolone Acetonide 40mg/mL — full drug profile →

Conditions studied

Vestibular Schwannoma — all drugs for Vestibular Schwannoma →

Sponsor

Medical University of Vienna

Who can join

Adults 18 to 90, any sex, with Vestibular Schwannoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients undergoing surgery of a vestibular schwannoma will be included in the study. Patients will receive triamcinolone acetonide 24h before surgery. During translabyrinthine surgery cochlear perilymph, perilymph from the semicircular canal and cerebrospinal fluid will be taken and analyzed for triamcinolone content. In patients undergoing middle fossa or retrosigmoid resection only cerebrospinal fluid will be taken and analyzed for triamcinolone acetonide level.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Vestibular schwannoma: genetic and epigenetic mechanisms, hearing loss, and emerging therapies.
Otaner F, Himic V, Vargas LO, Abikenari M, et al · · 2026 · PMID 42143176 · DOI 10.1007/s11060-026-05621-4

Verify or expand the search:

Other trials of Triamcinolone Acetonide 40mg/mL

Trials testing the same drug.

NCT05331664 — Dropless Pars Plana Vitrectomy Study · Phase 4 · recruiting
NCT05139875 — Comparing Intra-articular Betamethasone (Diprospan) and Triamcinolone Acetonide Injection in Knee Osteoarthritis · Phase 4 · completed
NCT05567081 — Efficacy of Ultrasound-Guided PRP Versus Corticosteroid Injection in Patients With Ulnar Neuropathy at Elbow · Phase 2, PHASE3 · completed
NCT04701593 — Using Triamcinolone Acetonide to Reduce Pain After Scleral Buckle Surgery · Phase 4 · completed
NCT04002037 — Differential Efficacy of Corticosteroid Solutions for Non-Operative Treatment of Digit Flexor Tenosynovitis · Phase 4 · terminated

Other recruiting trials for Vestibular Schwannoma

Currently open trials in the same condition.

NCT07364955 — Vestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma · NA · recruiting
NCT07130851 — Mapping of Vestibular Centers Activation Using fMRI in Patients With Vestibular Schwannoma · NA · active not recruiting
NCT06572475 — USPIO Enhanced MR Imaging in CNS Tumours (UMIC) · NA · recruiting
NCT06112509 — Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery · NA · recruiting
NCT05641441 — Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma · recruiting

Other Medical University of Vienna trials

Trials by the same sponsor.

NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04658836 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
Last refreshed: 24 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04658836.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing